Covid 19: 70% Vaccination Target Impossible, Low Turnout Blamed
- The Department of Health has warned that South Africa will not meet its 70% vaccination target
- The department has blamed the public for not meeting the target due to low turnout
- The country can vaccinate 300 000 people a day through a combination of private and public facilities
PAY ATTENTION: Click “See First” under the “Following” tab to see Briefly News on your News Feed!
PRETORIA - The Department of Health has admitted that it will fail to meet its 70% vaccination target by December.
However, the department has laid the blame at the feet of the public claiming that a decline in the number of people turning up to vaccinate has resulted in the current situation.
Despite efforts to get more people to get the jab, acting Director General Nicholas Crisp has admitted that their efforts have not been rewarded.
South Africa is currently able to vaccinate 300 000 people a day through a combination of public and private facilities.
Enjoy reading our stories? Download the BRIEFLY NEWS app on Google Play now and stay up-to-date with major South African news!
The department has revealed that over the past 24 hours Covid 19 cases have increased by 339 and 44 more people have died.
This brings the total number of casualties to 89 295 since the virus was first reported in South Africa.
SA told to brace itself for 4th wave of Covid 19 according to expert
Earlier, Briefly News reported that South Africa has been told to prepare for a fourth wave of Covid 19 by Dr Nicholas Crisp.
Dr Crisp is the Acting Director-General of the Health Department and he warned that if South Africa falls short of its vaccination target then a four-wave might sweep across the country.
How severe the wave will be will depend on how many people are vaccinated and if people continue to wear masks.
He said that the wave will most likely hit South Africa in December and that Covid will continue to be an issue for at least five years.
Covid19: Unvaccinated people more likely to die than those who take the jab, says Discovery
In similar news, Discovery medical aid conducted research on the Pfizer-BioNTech Covid-19 vaccine involving 1.2 million of its members. This research took place between 17 May and 23 September 2021.
The research focused on the Pfizer vaccine's ability to protect people from the Delta variant of Covid-19. Ryan Noach, the CEO of Discovery, reported that the research found that the Pfizer vaccine does in fact protect those who have been immunised against the dominant delta variant.
“This research was performed during a period when the delta variant was highly prevalent in South Africa. The vaccine effectiveness during a delta wave has not been widely reported on in large global studies, making this research even more relevant," Noach said.
Source: Briefly News